<1xbet 온라인ad prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet 온라인
  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2010
  5. T1xbet 온라인 Antiplatelet Agent Pletaal® (Nonproprietary Name: Cilostazol) T1xbet 온라인 Results of CSPS 2, a Large-Scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Posted on t1xbet 온라인 Online Version of T1xbet 온라인 Lancet Neurology

Otsuka Pharmaceuti1xbet 온라인l Co., Ltd.

Pharmaceuti1xbet 온라인ls
September 13, 2010

T1xbet 온라인 Antiplatelet Agent Pletaal® (Nonproprietary Name: C1xbet 온라인ostazol)
T1xbet 온라인 Results of CSPS 2, a Large-Scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Posted on t1xbet 온라인 Online Version of T1xbet 온라인 Lancet Neurology

Tokyo, Japan -- Otsuka Pharmaceutical Co., Ltd. today announced that t1xbet 온라인 results of CSPS 2,* a large-scale clinical trial of cilostazol (Product Name: Pletaal) in preventing recurrent strokes, were posted on t1xbet 온라인 online version of T1xbet 온라인 Lancet Neurology, a British major medical journal in neurology, on September 11, 2010.

  • * CSPS 2: C1xbet 온라인ostazol Stroke Prevention Study 2
Previous
Next
Latest Pharmaceuti1xbet 온라인l Business related News Releases
Most Recent Releases